Why the study?
Does elevated serum uric acid increase the risk of new-onset HFpEF and MACEs in hypertensive patients with left ventricular hypertrophy?
Population
1009 adult hypertensive patients with left ventricular hypertrophy and suspected left ventricular diastolic…
Comparison
Highest tertile of serum uric acid (>367 μmol L−1) vs Lowest tertile of serum uric acid (<302 μmol L−1)
Design
Cohort
Follow-up
median 7.2 years
Authors
Loading...
Hyperuricemia may identify high-risk hypertensive LVH patients for closer surveillance; leaves open whether lowering uric acid prevents HFpEF.
Does elevated serum uric acid increase the risk of new-onset HFpEF and MACEs in hypertensive patients with left ventricular hypertrophy?
Hyperuricemia is a significant predictor of new-onset HFpEF and major adverse cardiovascular events in hypertensive patients with left ventricular hypertrophy.
Gu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: